Jim Cramer Highlights Market Opportunities in Morning Meeting Points to Stock With Significant Upside Potential UK Government Unveils VAT Reduction on Theme Park Tickets and Childrens Meals to Ease CostofLiving Burden Microns New Milestone Dicks Earnings and Paxtons Primary Victory Highlight CNBCs Morning Squawk Jefferies Initiates Coverage on Compass Gas With Bullish View on Brazil Gas Market Reform AI Boom Intensifies Optical Tech Supply Constraints as Huawei Stages Chip Comeback Trump Seeks Totally Independent New Fed Chair Escalates Pressure on Powells Legacy Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Vera Bradley VRA Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Picture PRHIZ Q1 2024 Earnings Significant EPS Beat Surprises Markets TME Q1 2026 Earnings EPS Beat Fails to Lift Shares GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 UROY Q1 2026 Earnings Surprise Profit Amid Modest Market Reaction ZKH Group Limited ZKH Edges Higher as Stock Tests Key Resistance Trilogy Metals TMQ Edges Higher as Stock Consolidates Near Support Innovex International INVX Slips 24 Support Levels Tested After Recent Decline Lamb Weston LW Surges 222 as Investor Sentiment Improves Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing Dating Startups Innovate to Combat Fake Profiles Potentially Reshaping Online Dating Industry COP Q1 2026 Earnings EPS Beats Estimates by 132 but Stock Declines 323 P3 Health Partners Warrant PIIIW Nears Penny Territory Down 1093 at 002 TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges Sable Offshore Corp Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss SNBR Q1 2026 Earnings Staggering EPS Miss Signals Deep Operational Challenges AVD Q3 2025 Earnings Massive EPS Miss Sends Stock Lower SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports a Surprising Profit